Showing results (1201-1210 of 1,292) with videos related to
Sort By:
Pageof 130
Veterinary and Comparative Oncology|September 21, 2017
Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain DogsT Thaiwong, S Sirivisoot, M Takada, et al.Veterinary and Comparative Oncology|September 24, 2017
Oral melphalan for the treatment of relapsed canine lymphomaM L Mastromauro, S E Suter, M L Hauck, et al.Veterinary and Comparative Oncology|September 12, 2017
Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different dosesC F Saba, K R Vickery, C A Clifford, et al.Veterinary and Comparative Oncology|September 6, 2017
Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic targetF Millanta, J Impellizeri, L McSherry, et al.Veterinary and Comparative Oncology|May 20, 2016
Patterns of lymph node metastasis identified following bilateral mandibular and medial retropharyngeal lymphadenectomy in 31 dogs with malignancies of the headOwen T Skinner, Sarah E Boston, Carlos H de M SouzaVeterinary and Comparative Oncology|May 21, 2016
Association of breed and histopathological grade in canine mast cell tumoursH Mochizuki, A Motsinger-Reif, C Bettini, et al.Veterinary and Comparative Oncology|June 10, 2016
A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013)S E Rau, K E BurgessVeterinary and Comparative Oncology|October 11, 2014
Post-transplant malignant neoplasia associated with cyclosporine-based immunotherapy: prevalence, risk factors and survival in feline renal transplant recipientsC Wormser, A Mariano, E S Holmes, et al.Veterinary and Comparative Oncology|February 23, 2016
Use of indirect lymphography to identify sentinel lymph node in dogs: a pilot study in 30 tumoursH N Brissot, E G EderyVeterinary and Comparative Oncology|February 17, 2016
Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy responseM M Flórez, H B Fêo, G N da Silva, et al.Pageof 130